English
|
Spanish
Supporting oncology professionals through education
Login
Register
The content on this site is intended for healthcare professionals only
Menu
Home
News
Journal
Video
e
learning
Events
Conferences
About us
Keyword
Breast
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
Bone
Brain & nervous system
Haematology oncology
Hepatobiliary pancreatic
Paediatric
Neuroendocrine
Sarcomas
News
Latest news
Sign up for news alerts
Submit your news
Explore
Bone
Brain & nervous system
Breast
Colorectal & gastro
Haematology oncology
Head & neck
Hepatobiliary pancreatic
Lung & pleura
Melanoma & skin
Neuroendocrine
Ovary & gynaecology
Paediatric
Prostate & urology
Sarcomas
Journal information
Journal home
Charges
Editorial board
Founding editors
Editor-in-chief
Contact us
Author information
Submit article
Author guidelines
Editorial policies
Copyright information
Why publish with us
Reviewer information
Reviewer guidelines
Memberships
Videos
Recent videos
Sign up
Explore
Bone
Brain & nervous system
Breast
Colorectal & gastro
Haematology oncology
Head & neck
Hepatobiliary pancreatic
Lung & pleura
Melanoma & skin
Neuroendocrine
Ovary & gynaecology
Paediatric
Prostate & urology
Sarcomas
Conferences
Latest conferences
Sign up for latest coverage
Submit your event
About
e
cancer
About
e
cancer
Our founders
Funding statement
Contact us
Home
News
Journal
Video
e
learning
Events
Conferences
About us
Keyword
Breast
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
+
-
Bone
Brain & nervous system
Haematology oncology
Hepatobiliary pancreatic
Paediatric
Neuroendocrine
Sarcomas
Tamoxifen vs Aromatase Inhibitors and highlights of San Antonio Breast Cancer Symposium
Share :
SABCS 2008
10 - 14 Dec 2008
Please rate this video
The information in this video was of interest to me
The information in this video is likely to improve my clinical practice or research
I would recommend this video to my colleagues
Published:
9 Jan 2009
Views:
17637
Rating:
Save
Rate video
Professor Mitch Dowsett, Professor of Biochemical Endocrinology at the Institute of Cancer Research
Highlights of the San Antonio Breast Cancer Symposium, Aromatase Inhibtors vs Tamoxifen, Survival Benefit, BIG 1-98, Letrozole
Categories:
Breast
Drug development
Hormones/endocrine
Related Videos
CDK-4/6 inhibitors with endocrine treatment for metastatic breast cancer
Dr Sitna Mwanzi - Kenyatta National Hospital, Nairobi, Kenya
10 Jan 2024
Preoperative endocrine therapy in premenopausal women leads to sparing...
Dr Oleg Gluz - Krankenhaus Bethesda, Mönchengladbach, Germany
28 Dec 2023
OncoAlert round up July 28th to August 3rd, 2023
Dr Gil Morgan - Executive Director, OncoAlert
4 Aug 2023
CDK4/6 inhibitors added to first line show no greater benefit when compared to...
Dr Gabe Sonke - Netherlands Cancer Institute, Amsterdam, Netherlands
6 Jun 2023
ASCO 2023: Breast cancer research highlights
Dr Matteo Lambertini - San Martino Hospital, Genoa, Italy
5 Jun 2023
Adding ribociclib to endocrine therapy shows an improvement in invasive disease...
Prof Dennis Slamon - UCLA, Los Angeles, USA
3 Jun 2023
SOFT study: Clinical relevance of genomic alterations in premenopausal HR+...
Prof Sherene Loi - Peter MacCallum Cancer Centre, Melbourne, Australia
28 Mar 2023
Spindle cell lesions of the breast
Prof Cecily Quinn - St Vincent’s University Hospital, Dublin, Ireland
1 Feb 2023
Management of HER2 positive metastatic breast cancer treatment algorithm
Prof Sandra Swain - Georgetown University Medical Center, Washington DC, USA
31 Jan 2023
More from
e
cancer